Clinical Trial Update: VIS Opti-K Vision Improvement for Presbyopes

View source ↗

Summary

A clinical trial update for VIS Opti-K aimed at improving vision in presbyopes; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• Opti-K

Snippet

Sponsor: VIS, Inc. | Conditions: Presbyopia Correction | Status: ACTIVE_NOT_RECRUITING